Cargando…

Clearance of the SARS-CoV-2 Virus in an Immunocompromised Patient Mediated by Convalescent Plasma without B-Cell Recovery

Coronavirus disease (COVID-19) is a contagious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This case report presents a patient who had difficulty eradicating the corona virus due to being treated with Rituximab, which depletes B lymphocyte cells and therefore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basheer, Maamoun, Saad, Elias, Laskar, Orly, Schuster, Ofir, Rechnitzer, Hagai, Zisman-Rozen, Simona, Azoulay, David, Assy, Nimer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396366/ https://www.ncbi.nlm.nih.gov/pubmed/34445605 http://dx.doi.org/10.3390/ijms22168902

Ejemplares similares

Clinical Predictors of Mortality and Critical Illness in Patients with COVID-19 Pneumonia
por: Basheer, Maamoun, et al.
Publicado: (2021)

Convalescent Plasma Reduces Mortality and Decreases Hospitalization Stay in Patients with Moderate COVID-19 Pneumonia
por: Basheer, Maamoun, et al.
Publicado: (2021)

Increased Red Blood Cell Distribution Predicts Severity of Chronic Obstructive Pulmonary Disease Exacerbation
por: Saad, Elias, et al.
Publicado: (2023)

Liver Fat Storage Is a Better Predictor of Coronary Artery Disease than Visceral Fat
por: Basheer, Maamoun, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers
por: Bassal, Tamara, et al.
Publicado: (2022)

Cytokine Patterns in COVID-19 Patients: Which Cytokines Predict Mortality and Which Protect Against?
por: Basheer, Maamoun, et al.
Publicado: (2022)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Rapid, Sensitive and Reliable Ricin Identification in Serum Samples Using LC–MS/MS
por: Feldberg, Liron, et al.
Publicado: (2021)

Complete clearance of periungual warts in an immunocompromised patient using diluted intralesional bleomycin
por: Altalhab, Saad
Publicado: (2022)

Sex Differences in Plasma MicroRNA Biomarkers of Early and Complicated Diabetes Mellitus in Israeli Arab and Jewish Patients
por: Meerson, Ari, et al.
Publicado: (2019)

Whole-Cell Multiparameter Assay for Ricin and Abrin Activity-Based Digital Holographic Microscopy
por: Makdasi, Efi, et al.
Publicado: (2019)

Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19
por: Rodionov, Roman N, et al.
Publicado: (2021)

Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
por: Bloch, Evan M, et al.
Publicado: (2023)

WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
por: Franchini, Massimo, et al.
Publicado: (2023)

The detrimental danger of water-pipe (Hookah) transcends the hazardous consequences of general health to the driving behavior
por: Elias, Wafa, et al.
Publicado: (2012)

Approach to Solid Liver Masses in the Cirrhotic Patient
por: Assy, Nimer, et al.
Publicado: (2009)

Efficacy of convalescent plasma therapy in immunocompromised patients with COVID-19: A case report
por: Casarola, Genni, et al.
Publicado: (2021)

Insights from the Infection Cycle of VSV-ΔG-Spike Virus
por: Milrot, Elad, et al.
Publicado: (2022)

Convalescent plasma therapy in an immunocompromised patient with multiple COVID‐19 flares: a case report
por: Karaolidou, Frini, et al.
Publicado: (2021)

COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
por: Senefeld, Jonathon W., et al.
Publicado: (2023)

Acute respiratory failure in immunocompromised adults
por: Azoulay, Elie, et al.
Publicado: (2019)

Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2021)

Antibody Repertoire Analysis of Hepatitis C Virus Infections Identifies Immune Signatures Associated With Spontaneous Clearance
por: Eliyahu, Sivan, et al.
Publicado: (2018)

Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients
por: Beraud, Mickael, et al.
Publicado: (2022)

Specific and Rapid SARS-CoV-2 Identification Based on LC-MS/MS Analysis
por: Schuster, Ofir, et al.
Publicado: (2021)

Evaluating the efficacy of RT-qPCR SARS-CoV-2 direct approaches in comparison to RNA extraction
por: Israeli, Ofir, et al.
Publicado: (2020)

Time to SARS-CoV-2 PCR Clearance in Immunocompromising Conditions: Is Test-Based Removal From Isolation Necessary in Severely Immunocompromised Individuals?
por: Epstein, Rachel L, et al.
Publicado: (2021)

Coupling immuno-magnetic capture with LC–MS/MS(MRM) as a sensitive, reliable, and specific assay for SARS-CoV-2 identification from clinical samples
por: Schuster, Ofir, et al.
Publicado: (2022)

Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response
por: Marconato, Maddalena, et al.
Publicado: (2022)

Iron-Modified Blood Culture Media Allow for the Rapid Diagnosis and Isolation of the Slow-Growing Pathogen Francisella tularensis
por: Makdasi, Efi, et al.
Publicado: (2022)

Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment
por: Chen, Liang, et al.
Publicado: (2021)

High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patients
por: Huygens, Sammy, et al.
Publicado: (2023)

Relationship between Retinal Vascular Caliber and Coronary Artery Disease in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Josef, Pikkel, et al.
Publicado: (2013)

Gastrointestinal bleeding in critically ill immunocompromised patients
por: Catano, Jennifer, et al.
Publicado: (2021)

Minimally Invasive Diagnostic Strategy in Immunocompromised Patients with Pulmonary Infiltrates
por: Camous, Laurent, et al.
Publicado: (2010)

Development of an immunofluorescence assay for detection of SARS-CoV-2
por: Atiya-Nasagi, Yafit, et al.
Publicado: (2022)

Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients
por: Bele, Nicolas, et al.
Publicado: (2011)

Korean version of the convalescence and recovery evaluation: translation and linguistic validation
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

High-titre convalescent plasma therapy for an immunocompromised patient with systemic lupus erythematosus with protracted SARS-CoV-2 infection
por: Moutinho-Pereira, Sara, et al.
Publicado: (2021)

The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis
por: Assy, Nimer, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_c8f1ukkrdlfspael66ne7u6r1q